EZDIATECH
Ezdiatech is an in-vitro diagnostics company specializing in rapid, high-sensitivity, multiplex diagnostic solutions. Their core technology, the VEUS system, leverages proprietary magnetic particle technology, rapid reaction technology, fluorescence analysis modules, and AI multi-diagnostic analysis. This enables fast and accurate diagnoses within 15-50 minutes, offering multiplex testing for multiple markers with high sensitivity. Their key product, VEUPLEX™ TBI assay, is a multiplex blood test kit for diagnosing Traumatic Brain Injury (concussion) using GFAP and UCH-L1 biomarkers. The company has secured core technology through patents and is expanding its product portfolio into areas like heart disease and molecular diagnostics. Ezdiatech has received certifications such as the Ministry of Food and Drug Safety's Innovative Medical Device designation and New Excellent Technology (NET) certification.
EZDIATECH
Ezdiatech is an in-vitro diagnostics company specializing in rapid, high-sensitivity, multiplex diagnostic solutions. Their core technology, the VEUS system, leverages proprietary magnetic particle technology, rapid reaction technology, fluorescence analysis modules, and AI multi-diagnostic analysis. This enables fast and accurate diagnoses within 15-50 minutes, offering multiplex testing for multiple markers with high sensitivity. Their key product, VEUPLEX™ TBI assay, is a multiplex blood test kit for diagnosing Traumatic Brain Injury (concussion) using GFAP and UCH-L1 biomarkers. The company has secured core technology through patents and is expanding its product portfolio into areas like heart disease and molecular diagnostics. Ezdiatech has received certifications such as the Ministry of Food and Drug Safety's Innovative Medical Device designation and New Excellent Technology (NET) certification.